Total Payments
$12,049
2024 Payments
$133.91
Companies
5
Transactions
12
Medicare Patients
477
Medicare Billing
$359,155
Payment Breakdown by Category
Other$11,560 (95.9%)
Food & Beverage$488.48 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $7,560 | 1 | 62.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 2 | 33.2% |
| Food and Beverage | $488.48 | 9 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Brainsway USA INC | $11,683 | 4 | $0 (2023) |
| LivaNova USA, Inc. | $287.41 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $32.88 | 2 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $24.94 | 2 | $0 (2018) |
| Lundbeck LLC | $20.38 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.91 | 1 | LivaNova USA, Inc. ($133.91) |
| 2023 | $1,154 | 3 | Brainsway USA INC ($1,000) |
| 2022 | $7,560 | 1 | Brainsway USA INC ($7,560) |
| 2021 | $3,123 | 2 | Brainsway USA INC ($3,123) |
| 2018 | $63.78 | 4 | Neurocrine Biosciences, Inc. ($24.94) |
| 2017 | $14.42 | 1 | Janssen Pharmaceuticals, Inc ($14.42) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $133.91 | General |
| Category: Neurology | ||||||
| 11/01/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $142.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/02/2023 | Brainsway USA INC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 04/29/2022 | Brainsway USA INC | Brainsway Deep TMS (Device) | Honoraria | Cash or cash equivalent | $7,560.27 | General |
| Category: transcranial magnetic stimulation | ||||||
| 10/19/2021 | Brainsway USA INC | BrainsWay Deep TMS (Device) | Food and Beverage | Cash or cash equivalent | $122.87 | General |
| Category: Transcranial Magnetic Stimulation | ||||||
| 02/10/2021 | Brainsway USA INC | BrainsWay Deep TMS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Transcranial Magnetic Stimulation | ||||||
| 12/10/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROLOGY | ||||||
| 11/29/2018 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Neuroscience | ||||||
| 07/19/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 264 | 5,472 | $829,700 | $289,531 |
| 2022 | 3 | 69 | 304 | $115,650 | $47,589 |
| 2021 | 3 | 54 | 134 | $32,886 | $9,949 |
| 2020 | 4 | 90 | 179 | $42,197 | $12,085 |
Total Patients
477
Total Services
6,089
Medicare Billing
$359,155
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 826 | $330,400 | $113,159 | 34.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 47 | 3,283 | $245,775 | $80,920 | 32.9% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 14 | 239 | $95,600 | $41,137 | 43.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 43 | 721 | $107,980 | $36,670 | 34.0% |
| 90869 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent motor threshold redetermination with delivery and management | Office | 2023 | 13 | 35 | $21,000 | $8,762 | 41.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 32 | 69 | $13,400 | $3,701 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 31 | $7,750 | $2,953 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 31 | $5,425 | $2,077 | 38.3% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 29 | 237 | $2,370 | $150.70 | 6.4% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 11 | 236 | $94,400 | $40,637 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $14,850 | $4,872 | 32.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 28 | 38 | $6,400 | $2,080 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 73 | $13,667 | $3,987 | 29.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 41 | $11,113 | $3,220 | 29.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 19 | 20 | $8,106 | $2,742 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 102 | $19,161 | $5,696 | 29.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 26 | 32 | $12,481 | $3,371 | 27.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 24 | $6,520 | $1,906 | 29.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 21 | $4,035 | $1,112 | 27.5% |
About Dr. Wayne Bentham, MD
Dr. Wayne Bentham, MD is a Psychosomatic Medicine healthcare provider based in Vadnais Heights, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609952407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Bentham, MD has received a total of $12,049 in payments from pharmaceutical and medical device companies, with $133.91 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Honoraria" ($7,560).
As a Medicare-enrolled provider, Bentham has provided services to 477 Medicare beneficiaries, totaling 6,089 services with total Medicare billing of $359,155. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychosomatic Medicine
- Other Specialties Psychiatry, Psychiatry
- Location Vadnais Heights, MN
- Active Since 10/27/2006
- Last Updated 02/28/2023
- Taxonomy Code 2084P0015X
- Entity Type Individual
- NPI Number 1609952407
Products in Payments
- Brainsway Deep TMS (Device) $7,560
- BrainsWay Deep TMS (Device) $3,123
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $287.41
- INGREZZA (Drug) $24.94
- REXULTI (Drug) $20.38
- INVEGA TRINZA (Drug) $18.46
- INVEGA SUSTENNA (Drug) $14.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.